Literature DB >> 18624262

A survey of the management of gout in primary care.

D Owens1, B Whelan, G McCarthy.   

Abstract

There is no information available regarding current practice and standards in management of gout in Irish general practice. This study aims to assess current practice in the context of the 2006 EULAR evidence based recommendations for diagnosis and management of gout. A 20 point questionnaire was circulated to all 170 general practitioners in the North Dublin GP Partnership assessing frequency of diagnostic and therapeutic interventions undertaken. 91% of practitioners manage gout exclusively in primary care. 89% make a diagnosis on clinical grounds and 77% routinely measure serum urate. Diagnostic joint aspiration is rarely performed (3%). 86% routinely assess and manage risk factors for gout. 66% initiate urate-lowering therapy. Only 32% routinely monitor urate levels in patients receiving urate-lowering therapy. Thus, although management of gout in primary care in Ireland is generally in line with the EULAR recommendations some aspects of care remain suboptimal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18624262

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  16 in total

Review 1.  Management of gout in general practice--a systematic review.

Authors:  Andrew Jeyaruban; Sarah Larkins; Muriel Soden
Journal:  Clin Rheumatol       Date:  2014-09-17       Impact factor: 2.980

Review 2.  Optimizing current treatment of gout.

Authors:  Frances Rees; Michelle Hui; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2014-03-11       Impact factor: 20.543

3.  Systemic staging for urate crystal deposits with dual-energy CT and ultrasound in patients with suspected gout.

Authors:  Alexander Huppertz; Kay-Geert A Hermann; Torsten Diekhoff; Moritz Wagner; Bernd Hamm; Wolfgang A Schmidt
Journal:  Rheumatol Int       Date:  2014-03-12       Impact factor: 2.631

4.  Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire.

Authors:  Leslie R Harrold; Kathleen M Mazor; Amarie Negron; Jessica Ogarek; Cassandra Firneno; Robert A Yood
Journal:  Rheumatology (Oxford)       Date:  2013-04-25       Impact factor: 7.580

5.  Gout treatment: survey of Brazilian rheumatology residents.

Authors:  Rodrigo Balbino Chaves Amorim; Ana Beatriz Vargas-Santos; Leticia Rocha Pereira; Evandro Silva Freire Coutinho; Geraldo da Rocha Castelar-Pinheiro
Journal:  Clin Rheumatol       Date:  2017-01-19       Impact factor: 2.980

6.  Prevalence of comorbidities and management of gout in a tropical city in Australia.

Authors:  Andrew Jeyaruban; Muriel Soden; Sarah Larkins
Journal:  Rheumatol Int       Date:  2016-10-21       Impact factor: 2.631

Review 7.  Role of dual-energy CT in the diagnosis and follow-up of gout: systematic analysis of the literature.

Authors:  André Ramon; Amélie Bohm-Sigrand; Pierre Pottecher; Pascal Richette; Jean-Francis Maillefert; Herve Devilliers; Paul Ornetti
Journal:  Clin Rheumatol       Date:  2018-01-19       Impact factor: 2.980

8.  The management of gout in different clinical specialties in Turkey: a patient-based survey.

Authors:  Mehmet Akif Öztürk; Rıdvan Mercan; Kevser Gök; Ahmet Mesut Onat; Bünyamin Kısacık; Gezmiş Kimyon; Ayşe Balkarlı; Arif Kaya; Veli Çobankara; Mehmet Ali Balcı; ÖmerNuri Pamuk; Gözde Yıldırım Çetin; Mehmet Sayarlıoğlu; Soner Şenel; Mehmet Engin Tezcan; Adem Küçük; Kemal Üreten; Şafak Şahin; Abdurrahman Tufan
Journal:  Clin Rheumatol       Date:  2016-10-08       Impact factor: 2.980

Review 9.  Quality of life and quality of care for patients with gout.

Authors:  Jasvinder A Singh
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

10.  Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout.

Authors:  Angelo L Gaffo; Kenneth G Saag
Journal:  Core Evid       Date:  2010-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.